Restrictive hospital contracts are reshaping physician competition
Horizontal and vertical consolidation have spent years distorting U.S. health care pricing, and the pressure now reaches far beyond boardrooms. In day-to-day practice, the impact lands on independent physicians, patients, and employers through higher premiums, weaker physician autonomy, and fewer local options for care. A Maryland pathologist describes this as a market failure with visible bedside consequences: when large health systems gain enough regional power, contracting stops resembling competition and starts resembling coercion.
The most consequential tools are not always clinical. They are contractual.
All-or-nothing deals force insurers to buy the whole system
Dominant hospital systems often use all-or-nothing contracts to lock insurers into entire networks. The mechanism is blunt: if an insurer wants access to a system’s essential specialty center or flagship hospital, it must also accept the higher-cost, lower-value outpatient branches attached to that system. Instead of paying selectively for the strongest sites of care, the insurer is forced to bundle everything together, and those added costs flow into premiums and patient out-of-pocket expenses.
This structure does more than raise prices. It shields inefficient branches from ordinary market discipline. In a functional market, a high-performing service line earns patient volume because it delivers better value. Under bundled contracting, weaker sites ride the reputation and leverage of the stronger ones, then remain insulated from price pressure. The result is a commercial arrangement that rewards bargaining power over clinical value.
Anti-steering and gag clauses block price discovery
Two other provisions deepen the distortion. Anti-steering clauses prevent insurers from nudging patients toward lower-cost, in-network alternatives through incentives such as lower copays. Gag clauses block the disclosure of transparent pricing to patients and sometimes to physicians. Together, they suppress the information patients need to compare options and make ordinary consumer choice nearly impossible.
The practical consequence is simple: patients cannot steer toward affordable care if the contract forbids steering, and they cannot shop intelligently if prices are hidden. In medicine, where urgency and trust already limit consumer behavior, opacity creates a near-perfect setting for monopoly pricing. Once a health system controls the relevant referrals, facilities, and contract terms, cost escalation can proceed with very little friction.
Federal legislation targets the contracting machinery
Congress is beginning to respond directly to those mechanisms. The Healthy Competition for Better Care Act would ban all-or-nothing, anti-steering, and gag clauses in commercial contracts. Business coalitions, including The ERISA Industry Committee, have supported the idea because large employers bear much of the downstream burden when competition disappears and premiums climb.
The legislative logic is straightforward. If hospitals and health systems cannot force insurers to bundle elite centers with weaker satellites, then contracting returns to a more normal market function. Systems would have to compete on service quality, access, and price rather than on network leverage. For physicians trying to preserve independent practice, that shift matters because it weakens the financial incentives that reward sprawling corporate consolidation.
Cross-subsidies have become a shield for market power
Hospital executives often defend bundled contracts by arguing that revenue from profitable service lines is needed to subsidize unprofitable care, especially rural services. The argument has emotional appeal, but it also hides the financial mechanics from employers, patients, and regulators. When cross-subsidization occurs through opaque commercial contracts, it acts like a private tax collected without public oversight.
If rural facilities need support, transparent policy tools exist. Global budgets, targeted tax incentives, and direct federal grants can support access without forcing employers to absorb hidden costs in commercial negotiations. Those alternatives preserve accountability and make the financing of essential services visible. Hidden subsidy through contract leverage does not do that; it simply redistributes money in a way that is difficult to audit and easy to abuse.
Private equity adds another layer of financial strain
Private equity ownership has intensified the pressure on independent medicine. Over the past decade, private equity firms have acquired nursing homes, outpatient surgical centers, and physician practices at a rapid pace. These transactions are often built around short time horizons and heavy leverage, which creates a mismatch between financial engineering and the slower clinical obligations of patient care.
Sale-leaseback transactions illustrate the risk clearly. A firm buys a practice, separates the real estate, and then forces the practice to lease back the building it used to own. The clinical site now carries rent obligations designed to produce investor returns, not patient stability. Even before any clinical change appears, the organization has taken on a structural cost burden that can strain staffing, access, and long-term viability. In medicine, debt service can become a quiet threat to continuity of care.
New bills aim at ownership, transparency, and control
The federal Corporate Crimes Against Health Care Act would impose transparency requirements and criminal penalties for executive payouts when predatory financial engineering contributes to facility insolvency. Another proposal, the Stop Corporate Takeovers of Physicians Act, targets management services organizations that use “friendly physician” arrangements to strip doctors of meaningful control over scheduling and billing.
These bills attack different parts of the same problem. One addresses the money flow. The other addresses the administrative shell that can separate formal ownership from real professional control. For independent physicians, the issue is not abstract governance. When outside investors or management entities decide how care is scheduled, documented, or billed, the physician’s role can be reduced to a clinical signature on someone else’s business model.
State noncompete reform gives independent practice room to breathe
Federal antitrust enforcement can set a national floor, but state action still determines whether physicians can move, compete, and reopen local practices. Maryland has already taken a major step by sharply restricting health care noncompete covenants, banning them for lower- and mid-tier earners while limiting their duration and geographic reach for high earners. That change matters because noncompetes do more than protect employers; they can trap clinicians inside large systems and suppress workforce mobility in communities that already struggle to recruit care.
Physicians cannot build competitive independent practices when contract terms lock them into restrictive systems and prevent them from serving nearby patients after leaving employment. The combined effect of noncompetes, bundled hospital contracting, and private equity ownership is cumulative. Each mechanism narrows competition a little more. Together, they can turn a local market into a closed circuit.
Competition policy is now a clinical access issue
This is no longer just an antitrust debate for economists and lawyers. When corporate consolidation raises prices, blocks transparency, and removes independent physicians from the market, patients pay twice: once in premiums and again in reduced access. Employers absorb the costs through benefit design, and communities lose practices that once provided care close to home.
The current reform push aims at the mechanics that allow that cycle to continue. Whether the changes come from federal contracting bans, stricter oversight of private equity, or state limits on noncompetes, the central question is the same: will health care reward actual value, or will it keep rewarding leverage disguised as efficiency? The answer will depend on whether lawmakers act quickly enough to unwind the contract structures now shaping who can practice medicine and where patients can be seen.